Erythromycin Market - Size, Share, Outlook, and Forecast till 2027

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Erythromycin is an antibiotic used in the treatment or prevention of a wide range of bacterial infections. This antibiotic does not work in the event of viral infections such as common cold and flu. Erythromycin is thus used to treat respiratory tract infections, including bronchitis, pneumonia, Legionnaires' disease, and pertussis, diphtheria, as well as sexually transmitted diseases such as syphilis. It is also used to treat ear, intestine, gynecological, urinary tract, and skin infections. The erythromycin market is a rapidly growing market, as the drug is widely used across the globe and has been certified safe by the FDA.

Increasing prevalence of respiratory tract diseases due to growing volumes of toxic gases being let out in the environment is boosting demand for erythromycin, which in turn is fueling growth of the erythromycin market.

The downside of using this drug is that, it being an over-the-counter drug, it is often used for a variety of other purposes, even in mild cases or for non-bacterial infections. Using any antibiotic when it is not required causes the drug to not function for future infections. People thus, need to switch to other drugs instead of erythromycin. This in turn, poses a major restraint for growth of the erythromycin market.

Increasing number of companies are investing in the development of erythromycin owing to the lucrative opportunities, which in turn is augmenting growth of the erythromycin market.

In November 2017, Teligent, Inc.—a New Jersey-based specialty generic pharmaceutical company—received approval for its abbreviated new drug application (ANDA) from the U.S. FDA of Erythromycin Topical Solution USP, 2%.  This approval accounted for Teligent’s eighth approval during the same year and eighteenth approval from its internally-developed pipeline of topical generic pharmaceutical medicines.

In March 2018, Amneal Pharmaceuticals received FDA approval for Erythromycin Tablets USP for strengths of 250 mg and 500 mg.  The Amneal product is a therapeutic equivalent for the reference listed drug (RLD) Erythromycin Tablets from Arbor Pharmaceuticals and is the only other immediate release oral tablet available. The company sells its erythromycin tablets in 100-count bottles and has made them available to wholesalers, distributors, and direct to the trade.

Amneal aims at increasing access to affordable medications, and erythromycin tablets being products with limited availability, the company plans to benefit from the growing demand by providing patients and pharmacists with cost-effective options. According to January 2018 IQVIA market data, annual U.S. sales of erythromycin tablets accounted for US$ 84 million.

Chemicals and Materials

Global Erythromycin Thiocyanate Market Research Report 2020-2024

  Price : US$ 2,850   Date : Feb 2020
  Category : Chemicals and Materials   Pages : 152
Chemicals and Materials

Global and Chinese Erythromycin Industry, 2019 Market Research Report

  Price : US$ 3,000   Date : Apr 2018
  Category : Chemicals and Materials   Pages : 146
Healthcare and Pharmaceuticals

Global Erythromycin Thiocyanate Market Outlook 2019-2027

  Price : US$ 2,800   Date : Nov 2017
  Category : Healthcare and Pharmaceuticals   Pages : 104
Healthcare and Pharmaceuticals

2019 Europe Erythromycin Thiocyanate Industry Report

  Price : US$ 2,600   Date : Nov 2017
  Category : Healthcare and Pharmaceuticals   Pages : 111

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by:
  • Product Types
  • Drug Class
  • Indication
  • Applications
  • Services Types
  • End-users
  • Distribution channel
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers
  • Restraints
  • Pipeline Analysis
  • Incidence Rate
  • Epidemiology Analysis
  • Prevalence rate
  • Regulatory scenario
  • Industry trend
  • Pestle Analysis
  • Porter’s Analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Export-import analysis
  • Trade analysis
  • Competitive landscape
It helps the businesses in making investments decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.
Contact us

Sales Office (U.S.):
Worldwide Market Reports, 1001 4th Ave, #3200 Seattle, WA 98154, U.S.


Asia Pacific Intelligence Center (India):
Worldwide Market Reports 203, 2nd Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.


Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).

Secure Payment By:

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection


© 2020 Worldwide Market Reports. All rights reserved